Cargando…

Effectiveness of an Immersive Telemedicine Platform for Delivering Diabetes Medical Group Visits for African American, Black and Hispanic, or Latina Women With Uncontrolled Diabetes: The Women in Control 2.0 Noninferiority Randomized Clinical Trial

BACKGROUND: Medically underserved people with type 2 diabetes mellitus face limited access to group-based diabetes care, placing them at risk for poor disease control and complications. Immersive technology and telemedicine solutions could bridge this gap. OBJECTIVE: The purpose of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Suzanne E, Bragg, Alexa, De La Cruz, Barbara A, Winter, Michael R, Reichert, Matthew J, Laird, Lance D, Moldovan, Ioana A, Parker, Kimberly N, Martin-Howard, Jessica, Gardiner, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209787/
https://www.ncbi.nlm.nih.gov/pubmed/37163341
http://dx.doi.org/10.2196/43669
_version_ 1785046952314929152
author Mitchell, Suzanne E
Bragg, Alexa
De La Cruz, Barbara A
Winter, Michael R
Reichert, Matthew J
Laird, Lance D
Moldovan, Ioana A
Parker, Kimberly N
Martin-Howard, Jessica
Gardiner, Paula
author_facet Mitchell, Suzanne E
Bragg, Alexa
De La Cruz, Barbara A
Winter, Michael R
Reichert, Matthew J
Laird, Lance D
Moldovan, Ioana A
Parker, Kimberly N
Martin-Howard, Jessica
Gardiner, Paula
author_sort Mitchell, Suzanne E
collection PubMed
description BACKGROUND: Medically underserved people with type 2 diabetes mellitus face limited access to group-based diabetes care, placing them at risk for poor disease control and complications. Immersive technology and telemedicine solutions could bridge this gap. OBJECTIVE: The purpose of this study was to compare the effectiveness of diabetes medical group visits (DMGVs) delivered in an immersive telemedicine platform versus an in-person (IP) setting and establish the noninferiority of the technology-enabled approach for changes in hemoglobin A(1c) (HbA(1c)) and physical activity (measured in metabolic equivalent of task [MET]) at 6 months. METHODS: This study is a noninferiority randomized controlled trial conducted from February 2017 to December 2019 at an urban safety net health system and community health center. We enrolled adult women (aged ≥18 years) who self-reported African American or Black race or Hispanic or Latina ethnicity and had type 2 diabetes mellitus and HbA(1c) ≥8%. Participants attended 8 weekly DMGVs, which included diabetes self-management education, peer support, and clinician counseling using a culturally adapted curriculum in English or Spanish. In-person participants convened in clinical settings, while virtual world (VW) participants met remotely via an avatar-driven, 3D VW linked to video teleconferencing. Follow-up occurred 6 months post enrollment. Primary outcomes were mean changes in HbA(1c) and physical activity at 6 months, with noninferiority margins of 0.7% and 12 MET-hours, respectively. Secondary outcomes included changes in diabetes distress and depressive symptoms. RESULTS: Of 309 female participants (mean age 55, SD 10.6 years; n=195, 63% African American or Black; n=105, 34% Hispanic or Latina; n=151 IP; and n=158 in VW), 207 (67%) met per-protocol criteria. In the intention-to-treat analysis, we confirmed noninferiority for primary outcomes. We found similar improvements in mean HbA(1c) by group at 6 months (IP: –0.8%, SD 1.9%; VW: –0.5%, SD 1.8%; mean difference 0.3, 97.5% CI –∞ to 0.3; P<.001). However, there were no detectable improvements in physical activity (IP: –6.5, SD 43.6; VW: –9.6, SD 44.8 MET-hours; mean difference –3.1, 97.5% CI –6.9 to ∞; P=.02). The proportion of participants with significant diabetes distress and depressive symptoms at 6 months decreased in both groups. CONCLUSIONS: In this noninferiority randomized controlled trial, immersive telemedicine was a noninferior platform for delivering diabetes care, eliciting comparable glycemic control improvement, and enhancing patient engagement, compared to IP DMGVs. TRIAL REGISTRATION: ClinicalTrials.gov NCT02726425; https://clinicaltrials.gov/ct2/show/NCT02726425
format Online
Article
Text
id pubmed-10209787
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-102097872023-05-26 Effectiveness of an Immersive Telemedicine Platform for Delivering Diabetes Medical Group Visits for African American, Black and Hispanic, or Latina Women With Uncontrolled Diabetes: The Women in Control 2.0 Noninferiority Randomized Clinical Trial Mitchell, Suzanne E Bragg, Alexa De La Cruz, Barbara A Winter, Michael R Reichert, Matthew J Laird, Lance D Moldovan, Ioana A Parker, Kimberly N Martin-Howard, Jessica Gardiner, Paula J Med Internet Res Original Paper BACKGROUND: Medically underserved people with type 2 diabetes mellitus face limited access to group-based diabetes care, placing them at risk for poor disease control and complications. Immersive technology and telemedicine solutions could bridge this gap. OBJECTIVE: The purpose of this study was to compare the effectiveness of diabetes medical group visits (DMGVs) delivered in an immersive telemedicine platform versus an in-person (IP) setting and establish the noninferiority of the technology-enabled approach for changes in hemoglobin A(1c) (HbA(1c)) and physical activity (measured in metabolic equivalent of task [MET]) at 6 months. METHODS: This study is a noninferiority randomized controlled trial conducted from February 2017 to December 2019 at an urban safety net health system and community health center. We enrolled adult women (aged ≥18 years) who self-reported African American or Black race or Hispanic or Latina ethnicity and had type 2 diabetes mellitus and HbA(1c) ≥8%. Participants attended 8 weekly DMGVs, which included diabetes self-management education, peer support, and clinician counseling using a culturally adapted curriculum in English or Spanish. In-person participants convened in clinical settings, while virtual world (VW) participants met remotely via an avatar-driven, 3D VW linked to video teleconferencing. Follow-up occurred 6 months post enrollment. Primary outcomes were mean changes in HbA(1c) and physical activity at 6 months, with noninferiority margins of 0.7% and 12 MET-hours, respectively. Secondary outcomes included changes in diabetes distress and depressive symptoms. RESULTS: Of 309 female participants (mean age 55, SD 10.6 years; n=195, 63% African American or Black; n=105, 34% Hispanic or Latina; n=151 IP; and n=158 in VW), 207 (67%) met per-protocol criteria. In the intention-to-treat analysis, we confirmed noninferiority for primary outcomes. We found similar improvements in mean HbA(1c) by group at 6 months (IP: –0.8%, SD 1.9%; VW: –0.5%, SD 1.8%; mean difference 0.3, 97.5% CI –∞ to 0.3; P<.001). However, there were no detectable improvements in physical activity (IP: –6.5, SD 43.6; VW: –9.6, SD 44.8 MET-hours; mean difference –3.1, 97.5% CI –6.9 to ∞; P=.02). The proportion of participants with significant diabetes distress and depressive symptoms at 6 months decreased in both groups. CONCLUSIONS: In this noninferiority randomized controlled trial, immersive telemedicine was a noninferior platform for delivering diabetes care, eliciting comparable glycemic control improvement, and enhancing patient engagement, compared to IP DMGVs. TRIAL REGISTRATION: ClinicalTrials.gov NCT02726425; https://clinicaltrials.gov/ct2/show/NCT02726425 JMIR Publications 2023-05-10 /pmc/articles/PMC10209787/ /pubmed/37163341 http://dx.doi.org/10.2196/43669 Text en ©Suzanne E Mitchell, Alexa Bragg, Barbara A De La Cruz, Michael R Winter, Matthew J Reichert, Lance D Laird, Ioana A Moldovan, Kimberly N Parker, Jessica Martin-Howard, Paula Gardiner. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 10.05.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Mitchell, Suzanne E
Bragg, Alexa
De La Cruz, Barbara A
Winter, Michael R
Reichert, Matthew J
Laird, Lance D
Moldovan, Ioana A
Parker, Kimberly N
Martin-Howard, Jessica
Gardiner, Paula
Effectiveness of an Immersive Telemedicine Platform for Delivering Diabetes Medical Group Visits for African American, Black and Hispanic, or Latina Women With Uncontrolled Diabetes: The Women in Control 2.0 Noninferiority Randomized Clinical Trial
title Effectiveness of an Immersive Telemedicine Platform for Delivering Diabetes Medical Group Visits for African American, Black and Hispanic, or Latina Women With Uncontrolled Diabetes: The Women in Control 2.0 Noninferiority Randomized Clinical Trial
title_full Effectiveness of an Immersive Telemedicine Platform for Delivering Diabetes Medical Group Visits for African American, Black and Hispanic, or Latina Women With Uncontrolled Diabetes: The Women in Control 2.0 Noninferiority Randomized Clinical Trial
title_fullStr Effectiveness of an Immersive Telemedicine Platform for Delivering Diabetes Medical Group Visits for African American, Black and Hispanic, or Latina Women With Uncontrolled Diabetes: The Women in Control 2.0 Noninferiority Randomized Clinical Trial
title_full_unstemmed Effectiveness of an Immersive Telemedicine Platform for Delivering Diabetes Medical Group Visits for African American, Black and Hispanic, or Latina Women With Uncontrolled Diabetes: The Women in Control 2.0 Noninferiority Randomized Clinical Trial
title_short Effectiveness of an Immersive Telemedicine Platform for Delivering Diabetes Medical Group Visits for African American, Black and Hispanic, or Latina Women With Uncontrolled Diabetes: The Women in Control 2.0 Noninferiority Randomized Clinical Trial
title_sort effectiveness of an immersive telemedicine platform for delivering diabetes medical group visits for african american, black and hispanic, or latina women with uncontrolled diabetes: the women in control 2.0 noninferiority randomized clinical trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209787/
https://www.ncbi.nlm.nih.gov/pubmed/37163341
http://dx.doi.org/10.2196/43669
work_keys_str_mv AT mitchellsuzannee effectivenessofanimmersivetelemedicineplatformfordeliveringdiabetesmedicalgroupvisitsforafricanamericanblackandhispanicorlatinawomenwithuncontrolleddiabetesthewomenincontrol20noninferiorityrandomizedclinicaltrial
AT braggalexa effectivenessofanimmersivetelemedicineplatformfordeliveringdiabetesmedicalgroupvisitsforafricanamericanblackandhispanicorlatinawomenwithuncontrolleddiabetesthewomenincontrol20noninferiorityrandomizedclinicaltrial
AT delacruzbarbaraa effectivenessofanimmersivetelemedicineplatformfordeliveringdiabetesmedicalgroupvisitsforafricanamericanblackandhispanicorlatinawomenwithuncontrolleddiabetesthewomenincontrol20noninferiorityrandomizedclinicaltrial
AT wintermichaelr effectivenessofanimmersivetelemedicineplatformfordeliveringdiabetesmedicalgroupvisitsforafricanamericanblackandhispanicorlatinawomenwithuncontrolleddiabetesthewomenincontrol20noninferiorityrandomizedclinicaltrial
AT reichertmatthewj effectivenessofanimmersivetelemedicineplatformfordeliveringdiabetesmedicalgroupvisitsforafricanamericanblackandhispanicorlatinawomenwithuncontrolleddiabetesthewomenincontrol20noninferiorityrandomizedclinicaltrial
AT lairdlanced effectivenessofanimmersivetelemedicineplatformfordeliveringdiabetesmedicalgroupvisitsforafricanamericanblackandhispanicorlatinawomenwithuncontrolleddiabetesthewomenincontrol20noninferiorityrandomizedclinicaltrial
AT moldovanioanaa effectivenessofanimmersivetelemedicineplatformfordeliveringdiabetesmedicalgroupvisitsforafricanamericanblackandhispanicorlatinawomenwithuncontrolleddiabetesthewomenincontrol20noninferiorityrandomizedclinicaltrial
AT parkerkimberlyn effectivenessofanimmersivetelemedicineplatformfordeliveringdiabetesmedicalgroupvisitsforafricanamericanblackandhispanicorlatinawomenwithuncontrolleddiabetesthewomenincontrol20noninferiorityrandomizedclinicaltrial
AT martinhowardjessica effectivenessofanimmersivetelemedicineplatformfordeliveringdiabetesmedicalgroupvisitsforafricanamericanblackandhispanicorlatinawomenwithuncontrolleddiabetesthewomenincontrol20noninferiorityrandomizedclinicaltrial
AT gardinerpaula effectivenessofanimmersivetelemedicineplatformfordeliveringdiabetesmedicalgroupvisitsforafricanamericanblackandhispanicorlatinawomenwithuncontrolleddiabetesthewomenincontrol20noninferiorityrandomizedclinicaltrial